首页>
外国专利>
ONSET OF FORCE DEVELOPMENT AS A MARKER OF THROMBIN GENERATION
ONSET OF FORCE DEVELOPMENT AS A MARKER OF THROMBIN GENERATION
展开▼
机译：促成凝血酶生成的力量发展
展开▼
页面导航
摘要
著录项
相似文献
摘要
Platelet contractile force (PCF) is used as a surrogate marker of thrombin generation. PCF generation occurs concomitant with the burst of prothrombin fragment F 1+2 release. The time between assay start and PCF onset is identified as the thrombin generation time (TGT), and is used in assessing risk of bleeding, in diagnosing various disorders, and in monitoring the effects of pharmaceutical and other treatments. TGT is prolonged in clotting factor deficiencies and in the presence of direct and indirect thrombin inhibitors. TGT shortens to normal with clotting factor replacement and shortens with administration of rVIIa. TGT is short in thrombophilic states such as coronary artery disease, diabetes and thromboangiitis obliterans and prolongs toward normal with oral and intravenous anticoagulants.
展开▼
